Asthma

National Asthma Education and Prevention Program: Focused Guideline Updates

By

Tori Rodriguez, MA, LPC, AHC

The National Asthma Education and Prevention Program published focused updates to their asthma management guidelines.

The Role of Viral Infections in Asthma Development and Outcomes

By

Tori Rodriguez, MA, LPC, AHC

Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.

Exercise-Induced Bronchoconstriction With or Without Asthma: A Unique Challenge

By

Tori Rodriguez, MA, LPC, AHC

Patients with asthma who underwent exercise training have shown improvements in symptoms, pulmonary function, exercise capacity, and quality of life.

Prenatal Exposure to Ultrafine Particles Tied to Childhood Asthma

Prenatal ultrafine particle (UFP; <0.1 µm) exposure is associated with asthma development in children.

Benralizumab: Cost-Effective Add-On Therapy for Refractory Eosinophilic Asthma

By

Sheila Jacobs

In patients with refractory eosinophilic asthma, treatment with benralizumab is a cost-effective option to be used as add-on therapy.

Asthma Flares Decreased Among Black, Hispanic Patients During COVID-19 Pandemic

There was a substantial decrease in asthma exacerbations among Black and Hispanic patients during the COVID-19 pandemic.

Benefits of Switching From Omalizumab to Mepolizumab in Severe Eosinophilic Asthma

By

Virginia A. Schad, PharmD, RPh

Patients who have severe eosinophilic asthma that is uncontrolled on omalizumab may be effectively switched to mepolizumab.

Tezepelumab Improves Lung Function in Severe, Uncontrolled Asthma

By

Bryant Moeller

Patients with severe uncontrolled asthma receiving tezepelumab experienced fewer exacerbations, better lung function, and quality of life improvements compared with placebo.